Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Impact Therapeutics, Inc.
Scientific Title
A Phase I, Open-Label, Multi-Center, Dose Escalation and Expansion Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of IMP4297 in Combination With Temozolomide in Patients With Advanced Solid Tumors and Small Cell Lung Cancer